MMJ PhytoTech

38 articles about MMJ PhytoTech

• MMJ PhytoTech Ltd (ASX:MMJ) Annual Report to Shareholders

  9/24/2018

  MMJ PhytoTech Ltd (ASX:MMJ) (OTCMKTS:MMJJF) provides the Company's Annual Report to shareholders. 

• MMJ PhytoTech Ltd (ASX:MMJ) MediPharm Signs Customer Contracts Ahead of TSX-V Listing

  9/10/2018

  MMJ PhytoTech Limited is pleased to note the attached three news releases by MediPharm Labs Inc ("MediPharm") providing the details of three customer contracts signed over the past month or so and ahead of its listing on the TSX Venture Exchange ("TSX-V") expected later this month. 

• MMJ PhytoTech Ltd (ASX:MMJ) Ontario Cannabis Store Supply Agreements for Investee Companies

  9/10/2018

  MMJ PhytoTech Limited attaches a copy of a news release by the Ontario Cannabis Store ("OCS") confirming that it has entered into recreational cannabis supply agreements with a number of producers, including United Greeneries, a subsidiary of Harvest One Cannabis Inc.

• MMJ PhytoTech Ltd PhytoTech Therapeutics Phase II Clinical Trial Update

  1/31/2018

  MMJ PhytoTech is pleased to advise that it has received results from the first 10 patients who participated in the Phase 2 clinical trial undertaken by MMJ PhytoTech.

• MMJ PhytoTech Ltd to Acquire Strategic Position in Canadian Specialty Pharma and Healthcare Company Dosecann

  1/30/2018

  MMJ PhytoTech is pleased to advise that it has entered into an agreement to acquire Dosecann via the proposed placement of C$2.5 million in secured convertible debenture units.

• MMJ PhytoTech Ltd PhytoTech Therapeutics Ltd Management Changes

  12/1/2017

  MMJ PhytoTech wishes to advise that Dr Daphna Heffetz, CEO of the Company's subsidiary PTL, has tendered her resignation.

• MMJ PhytoTech Ltd Phase I Clinical Trial Results Published in International Medical Journal

  11/16/2017

  MMJ PhytoTech is pleased to advise that results from the Phase I Clinical Trial undertaken by MMJ's PhytoTech Therapeutics have been published.

• MMJ PhytoTech Ltd Commits A$500,000 Cornerstone Investment in eSense-Lab Limited

  11/14/2017

  MMJ will be issued 2,500,000 ordinary shares in eSense at the price of A$0.20 per share, and will receive 1 free option for every 2 shares issued at a $0.30 exercise price and expiry date of 3 years from date of issue.

• MMJ PhytoTech Strategy Expansion

  10/10/2017

• MMJ PhytoTech Appointment Of Chief Financial Officer

  6/15/2017

• MMJ PhytoTech Receives Approval To Conduct Phase II Clinical Trial For Treatment Of Multiple Sclerosis Symptoms

  5/15/2017

• MMJ PhytoTech Completion Of First Shipment Of Medicinal Cannabis Products Into Australia

  5/9/2017

• MMJ PhytoTech Harvest One Signs Funding Agreements With PanCann

  5/2/2017

• MMJ PhytoTech Quarterly Update And Appendix 4C

  5/1/2017

• MMJ PhytoTech: Harvest One Announces Closure Of United Greeneries And Satipharm Acquisition

  4/28/2017

• MMJ PhytoTech Completes Sale Of Satipharm And United Greeneries; Acquires Interest In Harvest One Cannabis Inc.

  4/28/2017

• MMJ PhytoTech First Cannabis Crop Harvested at Duncan Facility

  4/5/2017

• MMJ PhytoTech (ASX:MMJ) Canada Set To Legalize Recreational Cannabis By July 2018

  3/29/2017

• MMJ PhytoTech (ASX:MMJ) Australian Distribution Partner Receives Medicinal Cannabis Import Licence

  3/29/2017

• MMJ PhytoTech Satipharm Sales Update And Expansion Of European Distribution Network

  3/13/2017